Viewpoint

, Volume: 21( 2)

• View PDF
• Download PDF

Ultra Performance Liquid Chromatography and its Pharmaceutical Applications

*Correspondence:

Abhishek Tripathi
Department of Biotechnology,
Meerut Institute of Engineering and Technology,
Meerut,
Uttar Pradesh,
India
E-mail:abhishek.tripathi.bt.2017@miet.ac.in

Abstract

Opinion

Ultra-Performance Liquid Chromatography (UPLC) is a chromatographic system with a 1.7 m reverse-phase packing material and a pressure range of 6000-15000 psi (conventional HPLC employs 3-5 m packing material and runs between 2000 psi and 4000 psi). Because of the reduced band broadening, the signal-to-noise ratio (S/N) is higher, and thus a climb in sensitivity. For complex mixture separation, this has resulted in improved chromatographic peak resolution, as well as increased speed and sensitivity. For a 10-minute separation, typical peak widths formed by UPLC are in the range of 1-2 seconds. The issue of ion suppression from coeluting peaks is greatly reduced thanks to UPLC's much improved chromatographic resolution. For analyzing complex mixtures, UPLC coupled to a Q-TOF mass spectrometer (Quadrupole Time-of-Flight Mass Spectrometry) and it is a powerful tool. UPLC is a highly sensitive, dynamic, and efficient technique with increased resolution that uses less solvent and produces quicker results, making it both cost-effective and environmentally friendly. This chromatographic approach also reduces the amount of mobile-phase volume by 80% with much smaller operation time of 1.5 min. Furthermore, because of the smaller particle size, the pressure should rise to 1000 bars or higher, increasing the retention factor of the separation. Furthermore, it produces resolved peaks in the chromatogram and provides for precise simultaneous analysis of a variety of analytes. However, there is one downside to using UPLC that high pressure builds up in the column during the analysis, as a result, chromatographic columns may be destroyed or have their life expectancy shortened. When compared to HPLC with a short runtime, UPLC reduces mobile phase volume consumption by at least 80%. (even less than 1 min). The smaller particles increase the pressure to 1000 bars or more, which will increase the separation's retention factor by itself. In the UPLC, a smaller injection volume is required, resulting in increased efficiency and resolution. The mobile phase viscosity is reduced as the column temperature rises, resulting in a high diffusion coefficient and flow rate with minimal productivity loss and an increase in column back pressure. UPLC is a modified version of HPLC that benefits from recent advances in particle chemistry performance, system optimization, detector design, data processing, and control.

The effect of temperature on the parameters discussed here is an extra factor to think about. A more in-depth conversation is beyond the scope of this paper, and our group's recent research on the impacts of temperature on kinetic plots will be reported elsewhere. However, it should be noted that by using a higher temperature, quicker analyses at a given maximum pressure are possible (through the reduction in mobile phase viscosity). Temperature has the effect of moving particle size envelopes to lower t0/N numbers, which is nearly the same for all particle sizes. As a result, working at higher temperatures may improve the results reported here at 40°C. Our current research focuses on using a combination of high temperature and high pressure to get more effective and quicker analyses than has been feasible with commercial instrumentation so far. When compared to existing HPLC systems, UPLC has been judged in terms of realistic gains in speed and efficiency. The residual temperature effect under non-ideal adiabatic conditions, lower packing efficiency, and additional column band broadening are all blamed for a slightly higher-than-expected C-term measured from experimental Knox plots. When compared to 5 μm and 3.5 μm particles, the combination of high optimum flow rates and shorter column lengths makes for a speed increase of roughly 4.3 and 3.5 times, respectively, without compromising efficiency.

Pharmaceutical development is an important part of the process that occurs between the discovery of a chemical entity with therapeutic potential and the commercialization and widespread use of a new medicine. There are many tasks involved, including scaling up the synthetic path from bench to plant scale as well as the construction of a pill or other dosage form of the new medicine that can be mass-produced. Analytical chemistry supports these operations by assisting in the understanding of the effect of changes in the manufacturing path and scale on the quality and consistency of the dosage form. UPLC is one of the most common analytical approaches for ensuring the quality and consistency of both the chemical entity and the dosage form. For example, UPLC is used to determine the purity of various batches of a chemical entity, ensuring that the material used in clinical trials is of the same high quality as that used in toxicological studies. UPLC is often used to ascertain if any chemical degradation occurs within the dosage form over time, which aids in determining the shelf life.

Porous packing materials are commonly used in UPLC in pharmaceutical development due to the large sample concentration ranges inherent in purity evaluation. Porous packing materials that can resist greater pressures are now available, and they've been shown to hold far more samples than non-porous packing. These materials have also been reported to be packed into 1 mm diameter columns.